Doctors Note Logo

Published on: 8/18/2026

Why Adult Bones Soften: Hypophosphatasia Reality & Next Steps

Adult bones soften when mineralization fails, most often from vitamin D deficiency, low phosphate, kidney or gut malabsorption issues, certain medications, or hypophosphatasia (HPP), a rare genetic condition caused by low alkaline phosphatase activity that can appear in adulthood as stress fractures, foot and thigh pain, early tooth loss, and stubborn "osteoporosis" that does not improve with standard treatment. A persistently low ALP result is the key clue that separates HPP from osteomalacia and osteoporosis, and it matters because common bone drugs like bisphosphonates may worsen HPP while targeted enzyme therapy exists. Next steps typically include repeat ALP testing, vitamin B6 and urinary phosphoethanolamine levels, genetic testing, and referral to a metabolic bone specialist. There are several overlapping causes and important cautions to consider, so review the complete details below before assuming your soft or fragile bones are simple osteoporosis. Since these symptoms overlap so heavily, a free, instant, online symptom check can help you organize what you are experiencing and understand which questions and tests to raise with your doctor next.

Last reviewed for medical accuracy: 08/18/2026

answer background

Explanation

Why Adult Bones Soften: Hypophosphatasia Reality & Next Steps

Bone health often declines with age, but when adult bones soften beyond typical changes, an uncommon metabolic disorder—hypophosphatasia—may be at play. Hypophosphatasia in adults is a rare genetic condition marked by deficient activity of the enzyme alkaline phosphatase (ALP). Without enough ALP, minerals like calcium and phosphate fail to bind properly in bone, leading to weakened structure, chronic pain, and recurrent fractures. This guide explains why adult bones soften in hypophosphatasia, how to recognize signs, and what steps to take next.


What Is Hypophosphatasia?

Hypophosphatasia is an inherited disorder affecting bone and tooth mineralization. It occurs when mutations in the ALPL gene reduce the production or function of tissue-non-specific alkaline phosphatase (TNSALP). TNSALP helps break down compounds that inhibit mineral deposition. In hypophosphatasia, these inhibitors accumulate, preventing proper bone hardening.

Key points:

  • Mutations in the ALPL gene lower ALP enzyme activity.
  • Defective mineralization leads to soft, fragile bones.
  • Severity varies widely: from life-threatening infantile forms to mild adult presentations.

Hypophosphatasia in adults often emerges later in life, sometimes decades after birth, with symptoms ranging from mild bone pain to severe fractures.


Why Adult Bones Soften

In healthy bones, a balance of bone-forming cells (osteoblasts) and bone-resorbing cells (osteoclasts) maintains strength. ALP is crucial for osteoblasts to load calcium and phosphate into the bone matrix. When ALP falls below normal levels:

  1. Accumulation of Inhibitors

    • Molecules like inorganic pyrophosphate (PPi) build up.
    • PPi directly blocks mineral deposition in bone.
  2. Defective Mineral Crystals

    • Calcium-phosphate crystals (hydroxyapatite) cannot form properly.
    • The bone matrix remains unmineralized or under-mineralized.
  3. Weakened Bone Structure

    • Bones lose rigidity and become prone to bending or breaking.
    • Microfractures may develop and fail to heal normally.
  4. Systemic Effects

    • Low ALP can also affect muscle strength and dental health (early tooth loss, cavities).

These factors combine to soften adult bones, making everyday activities riskier and leading to chronic discomfort.


Recognizing Symptoms in Adults

Hypophosphatasia in adults can be subtle at first. Common signs include:

  • Bone and Joint Pain
    Chronic discomfort in hips, knees, and lower back.
  • Recurrent Fractures
    Stress fractures in the feet, wrists, or ribs after minimal trauma.
  • Muscle Weakness
    Difficulty climbing stairs or rising from a chair.
  • Dental Issues
    Loose teeth, early loss of adult teeth, or frequent cavities.
  • Fatigue and Mobility Issues
    Persistent tiredness and a waddling gait.
  • Lab Findings
    • Low serum alkaline phosphatase levels (below age-appropriate ranges).
    • Elevated substrates such as pyridoxal 5′-phosphate (vitamin B6) and PPi.

Because these symptoms overlap with osteoporosis and other conditions, hypophosphatasia in adults is often misdiagnosed or overlooked. If you’ve had unexplained fractures or persistent bone pain despite normal vitamin D and calcium levels, consider discussing hypophosphatasia with your doctor.


Diagnosis

Accurate diagnosis of hypophosphatasia in adults relies on a combination of blood tests, imaging, and genetic analysis:

  1. Blood Tests

    • Confirm low alkaline phosphatase (ALP) activity.
    • Measure elevated vitamin B6 (pyridoxal 5′-phosphate) and PPi.
  2. Imaging Studies

    • X-rays may show pseudofractures (Looser’s zones) or areas of poor mineralization.
    • Bone density scans (DEXA) can reveal decreased mineral content but may not distinguish hypophosphatasia from osteoporosis.
  3. Genetic Testing

    • Identifies mutations in the ALPL gene to confirm diagnosis.
    • Helps predict disease severity and informs family planning.
  4. Differential Diagnosis

    • Rule out other causes of low ALP: malnutrition, hypothyroidism, certain medications.
    • Exclude other metabolic bone disorders like osteomalacia or Paget’s disease.

Early and accurate diagnosis of hypophosphatasia in adults enables prompt treatment, reducing fracture risk and improving quality of life.


Treatment Options

While hypophosphatasia in adults currently has no cure, several therapeutic strategies can help manage symptoms and strengthen bones:

• Enzyme Replacement Therapy (ERT)
– Asfotase alfa: A recombinant ALP administered by injection under the skin.
– Shown to improve bone mineralization, reduce fractures, and ease pain.

• Pain Management
– Nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen for pain relief.
– Avoid long-term opioid use when possible.

• Physical Therapy
– Low-impact exercises (swimming, cycling) to build muscle strength without overstressing bones.
– Balance training to reduce fall risk.

• Nutritional Support
– Adequate dietary calcium and vitamin D within recommended daily allowances.
– Avoid excessive calcium or phosphate supplements that could disrupt mineral balance.

• Orthopedic Care
– Bracing or surgery for non-healing fractures or severe deformities.
– Custom orthotics to improve gait and reduce stress on fragile bones.

Close monitoring by a multidisciplinary team—endocrinologist, rheumatologist, geneticist, orthopedist—ensures the right combination of therapies.


Living with Hypophosphatasia in Adults

Adjusting to life with hypophosphatasia in adults involves proactive self-care and regular medical follow-up:

  • Stay Active Safely
    Choose activities that strengthen bones and muscles without high impact.
  • Home Modifications
    Install grab bars, ensure good lighting, and remove tripping hazards.
  • Dental Care
    Maintain excellent oral hygiene and schedule regular dental check-ups.
  • Support Networks
    Join patient advocacy groups (e.g., National Organization for Rare Disorders) or online forums for shared experiences and coping strategies.
  • Mental Health
    Chronic pain and mobility limitations can affect mood. Seek counseling or support groups as needed.

By combining medical treatments with lifestyle adjustments, many adults with hypophosphatasia maintain active, fulfilling lives.


Next Steps

If you suspect hypophosphatasia in adults could explain your bone pain or fractures, start by gathering information:

  1. Track your symptoms, fractures, and any dental issues.
  2. Share this record with your primary care physician or specialist.
  3. Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to explore possible causes and prepare for your medical visit.
  4. Ask about blood tests for alkaline phosphatase and genetic screening for ALPL mutations.

Always speak to a doctor about anything that could be life-threatening or serious. Early evaluation and intervention can make a significant difference in managing hypophosphatasia and protecting your bone health.

(References)

  • * Inoue M. [Hypophosphatasia]. Nihon Rinsho. 2006 Jun 28;Suppl 2:104-7. PMID: 16817361.

  • * Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Dahir KM, Nunes ME. Hypophosphatasia. 1993. PMID: 20301329.

  • * Rockman-Greenberg C. Hypophosphatasia. Pediatr Endocrinol Rev. 2013 Jun;10 Suppl 2:380-8. PMID: 23858621.

  • * Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Lewiecki EM. Osteoporosis: Clinical Evaluation. 2000. PMID: 25905277.

  • * Whyte MP. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016 Apr;12(4):233-46. doi: 10.1038/nrendo.2016.14. Epub 2016 Feb 19. PMID: 26893260.

  • * Riancho JA. Diagnostic Approach to Patients with Low Serum Alkaline Phosphatase. Calcif Tissue Int. 2023 Mar;112(3):289-296. doi: 10.1007/s00223-022-01039-y. Epub 2022 Nov 8. PMID: 36348061.

  • * Cianferotti L. Osteomalacia Is Not a Single Disease. Int J Mol Sci. 2022 Nov 28;23(23). doi: 10.3390/ijms232314896. Epub 2022 Nov 28. PMID: 36499221; PMCID: PMC9740398.

  • * Schini M, Vilaca T, Gossiel F, Salam S, Eastell R. Bone Turnover Markers: Basic Biology to Clinical Applications. Endocr Rev. 2023 May 8;44(3):417-473. doi: 10.1210/endrev/bnac031. PMID: 36510335; PMCID: PMC10166271.

  • * Rush E, Brandi ML, Khan A, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Lewiecki EM, Linglart A, M'Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Roux C, Seefried L, Starling SR, Ward L, Yao L, Brignardello-Petersen R, Simmons JH. Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group. Osteoporos Int. 2024 Jan;35(1):1-10. doi: 10.1007/s00198-023-06843-2. Epub 2023 Nov 20. PMID: 37982855; PMCID: PMC10786745.

  • * Rao SD. Grading Pseudo Fractures. Calcif Tissue Int. 2025 May 14;116(1):74. doi: 10.1007/s00223-025-01383-9. Epub 2025 May 14. PMID: 40366410.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.